rs17878649
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000769.4(CYP2C19):c.169-47G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00405 in 1,598,240 control chromosomes in the GnomAD database, including 231 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0084 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 209 hom. )
Consequence
CYP2C19
NM_000769.4 intron
NM_000769.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.244
Publications
8 publications found
Genes affected
CYP2C19 (HGNC:2621): (cytochrome P450 family 2 subfamily C member 19) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.056 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CYP2C19 | ENST00000371321.9 | c.169-47G>A | intron_variant | Intron 1 of 8 | 1 | NM_000769.4 | ENSP00000360372.3 | |||
| CYP2C19 | ENST00000480405.2 | c.169-47G>A | intron_variant | Intron 1 of 2 | 1 | ENSP00000483847.1 | ||||
| ENSG00000276490 | ENST00000464755.1 | n.932-47G>A | intron_variant | Intron 6 of 13 | 2 | ENSP00000483243.1 | ||||
| CYP2C19 | ENST00000645461.1 | n.1175G>A | non_coding_transcript_exon_variant | Exon 1 of 7 |
Frequencies
GnomAD3 genomes AF: 0.00834 AC: 1269AN: 152106Hom.: 20 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1269
AN:
152106
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00689 AC: 1690AN: 245252 AF XY: 0.00620 show subpopulations
GnomAD2 exomes
AF:
AC:
1690
AN:
245252
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00359 AC: 5194AN: 1446016Hom.: 209 Cov.: 28 AF XY: 0.00356 AC XY: 2556AN XY: 718858 show subpopulations
GnomAD4 exome
AF:
AC:
5194
AN:
1446016
Hom.:
Cov.:
28
AF XY:
AC XY:
2556
AN XY:
718858
show subpopulations
African (AFR)
AF:
AC:
748
AN:
33038
American (AMR)
AF:
AC:
31
AN:
44160
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25506
East Asian (EAS)
AF:
AC:
3656
AN:
39568
South Asian (SAS)
AF:
AC:
295
AN:
84864
European-Finnish (FIN)
AF:
AC:
7
AN:
52890
Middle Eastern (MID)
AF:
AC:
8
AN:
5708
European-Non Finnish (NFE)
AF:
AC:
123
AN:
1100572
Other (OTH)
AF:
AC:
326
AN:
59710
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
260
519
779
1038
1298
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00839 AC: 1277AN: 152224Hom.: 22 Cov.: 32 AF XY: 0.00847 AC XY: 630AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
1277
AN:
152224
Hom.:
Cov.:
32
AF XY:
AC XY:
630
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
866
AN:
41548
American (AMR)
AF:
AC:
28
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
319
AN:
5184
South Asian (SAS)
AF:
AC:
24
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10574
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16
AN:
68010
Other (OTH)
AF:
AC:
24
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
62
124
187
249
311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
162
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.